Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage

Cancer. 1996 May 1;77(9):1844-9. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1844::AID-CNCR13>3.0.CO;2-#.

Abstract

Background: There is little information regarding associations between magnetic resonance imaging (MRI) enhancement and biologic parameters of breast carcinoma. A prospective study was undertaken to correlate MRI dynamic contrast enhancement features with cell proliferative activity, as determined by DNA S-phase percentage.

Methods: Seventeen patients with invasive breast cancer underwent MRI at 1.5 tesla using a dynamic gadolinium-enhanced spoiled gradient recall echo technique. DNA analysis of samples of the excised lesions was then performed using flow cytometry.

Results: Invasive carcinomas with high DNA S-phase percentages (> or = 6.9%, the median value in this study), a measure of increased cell proliferation, were associated with a peripheral MRI enhancement pattern in 4 of 6 (67%) lesions compared with 0 of 11 carcinomas with lower DNA S-phase percentages (< or = 6.9%) (P = 0.006). There was no significant association between a high DNA S-phase percentage and greater MRI enhancement amplitude, rate, or washout. There was no significant association between aneuploid DNA content and any MRI enhancement feature.

Conclusions: Increased cell proliferation in invasive breast carcinoma, as determined by high DNA S-phase percentage, is significantly associated with a peripheral MRI enhancement pattern but unrelated to greater MRI enhancement amplitude, rate, or washout.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aneuploidy
  • Breast Neoplasms / pathology*
  • Carcinoma, Ductal, Breast / pathology*
  • Carcinoma, Ductal, Breast / secondary
  • Carcinoma, Lobular / pathology
  • Cell Division
  • Contrast Media
  • DNA, Neoplasm / analysis
  • Drug Combinations
  • Female
  • Flow Cytometry
  • Gadolinium
  • Gadolinium DTPA
  • Humans
  • Image Enhancement* / methods
  • Lymphatic Metastasis
  • Magnetic Resonance Imaging* / methods
  • Meglumine
  • Middle Aged
  • Neoplasm Invasiveness
  • Organometallic Compounds
  • Pentetic Acid / analogs & derivatives
  • Prospective Studies
  • S Phase

Substances

  • Contrast Media
  • DNA, Neoplasm
  • Drug Combinations
  • Organometallic Compounds
  • Meglumine
  • Pentetic Acid
  • Gadolinium
  • Gadolinium DTPA